Browsing byAuthorBöhm, M

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 12 to 18 of 18< previous 
Issue DateTitleAuthor(s)
2018-09-01Pair-matched patient-reported quality of life and early oncological control following focal irreversible electroporation versus robot-assisted radical prostatectomyScheltema, MJ; Chang, JI; Böhm, M; van den Bos, W; Blazevski, A; Gielchinsky, I; Kalsbeek, AMF; van Leeuwen, PJ; Nguyen, TV; de Reijke, TM; Siriwardana, AR; Thompson, JE; de la Rosette, JJ; Stricker, PD
2018-09PHARMacy-based interdisciplinary program for patients with Chronic Heart Failure (PHARM-CHF): rationale and design of a randomized controlled trial, and results of the pilot study.Laufs, U; Griese-Mammen, N; Krueger, K; Wachter, A; Anker, SD; Koehler, F; Rettig-Ewen, V; Botermann, L; Strauch, D; Trenk, D; Böhm, M; Schulz, M
2022-12Sacubitril/valsartan in heart failure: efficacy and safety in and outside clinical trials.Abdin, A; Schulz, M; Riemer, U; Hadëri, B; Wachter, R; Laufs, U; Bauersachs, J; Kindermann, I; Vukadinović, D; Böhm, M
2020-07-23The impact of pharmacist/physician care on quality of life in elderly heart failure patients: results of the PHARM-CHF randomized controlled trial.Schulz, M; Griese-Mammen, N; Schumacher, PM; Anker, SD; Koehler, F; Ruckes, C; Rettig-Ewen, V; Wachter, R; Trenk, D; Böhm, M; Laufs, U
2022Trends in Ezetimibe Prescriptions as Monotherapy or Fixed-Dose Combination in Germany 2012-2021.Katzmann, JL; Kieble, M; Enners, S; Böhm, M; Mahfoud, F; Laufs, U; Schulz, M
2022-02-27Use of fixed-dose combination antihypertensives in Germany between 2016 and 2020: an example of guideline inertia.Mahfoud, F; Kieble, M; Enners, S; Kintscher, U; Laufs, U; Böhm, M; Schulz, M
2021-11Utilization of drugs with reports on potential efficacy or harm on COVID-19 before, during, and after the first pandemic wave.Enners, S; Gradl, G; Kieble, M; Böhm, M; Laufs, U; Schulz, M